Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China flag China · Delayed Price · Currency is CNY
12.63
+0.35 (2.85%)
Oct 23, 2026, 3:04 PM CST

SHE:300401 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,2541,2201,2211,0821,3971,107
Other Revenue
17.717.722.4512.9320.399.75
1,2711,2371,2431,0951,4181,117
Revenue Growth
2.42%-0.47%13.58%-22.78%26.89%69.40%
Cost of Revenue
691.66555.88519.59441.4486.37350.66
Gross Profit
579.76681.52723.7653.25931.14766.44
Selling, General & Admin
179.82234.8308.87378.77444.55257.61
Research & Development
78.5565.4683.7890.9170.3459.28
Other Operating Expenses
20.6518.5113.2416.4416.243.48
Operating Expenses
276.91320.89407.84483.74533.66320.69
Operating Income
302.84360.63315.86169.51397.48445.75
Interest Expense
-32.47-32.47-35.63-38.41-21.82-10.81
Interest & Investment Income
10.329.6411.0120.5413.7532.49
Currency Exchange Gain (Loss)
-1.92-1.926.317.0211.1-2.79
Other Non Operating Income (Expenses)
-24.35-0.69-0.35-0.3-0.65-0.19
EBT Excluding Unusual Items
254.42335.19297.19158.36399.86464.46
Gain (Loss) on Sale of Investments
1.853.770.25-0.34-2.830.4
Gain (Loss) on Sale of Assets
-0.06-2.2431.53-0.0417.876.22
Asset Writedown
-2.16-3.98-0.44-0.22-1.01-0.09
Other Unusual Items
19.7619.7630.1753.2728.6748.38
Pretax Income
273.82352.5358.69211.04442.48589.37
Income Tax Expense
35.347.6449.4818.758.7675.42
Earnings From Continuing Operations
238.52304.86309.21192.35383.72513.94
Minority Interest in Earnings
0.010.010---30.18
Net Income
238.52304.86309.21192.35383.72483.77
Net Income to Common
238.52304.86309.21192.35383.72483.77
Net Income Growth
-20.97%-1.41%60.76%-49.87%-20.68%83.79%
Shares Outstanding (Basic)
542544542550548544
Shares Outstanding (Diluted)
593598595601548544
Shares Change
2.05%0.53%-1.07%9.65%0.85%7.38%
EPS (Basic)
0.440.560.570.350.700.89
EPS (Diluted)
0.400.510.520.320.700.89
EPS Growth
-22.56%-1.92%62.50%-54.29%-21.35%71.15%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
125.65112.78-13.97-84.57-2.89-203.33
Free Cash Flow Per Share
0.210.19-0.02-0.14-0.01-0.37
Dividend Per Share
0.1130.1130.1140.0710.1400.188
Dividend Growth
-0.88%-0.88%60.56%-49.29%-25.53%82.52%
Gross Margin
45.60%55.08%58.21%59.68%65.69%68.61%
Operating Margin
23.82%29.14%25.41%15.48%28.04%39.90%
Profit Margin
18.76%24.64%24.87%17.57%27.07%43.31%
Free Cash Flow Margin
9.88%9.11%-1.12%-7.72%-0.20%-18.20%
EBITDA
497.68538.72471.63302.82458.27490.2
EBITDA Margin
39.14%43.54%37.93%27.66%32.33%43.88%
D&A For EBITDA
194.84178.09155.77133.3160.7944.45
EBIT
302.84360.63315.86169.51397.48445.75
EBIT Margin
23.82%29.14%25.41%15.48%28.04%39.90%
Effective Tax Rate
12.89%13.52%13.80%8.86%13.28%12.80%
Revenue as Reported
1,2711,2371,2431,0951,4181,117
Advertising Expenses
-3.112.370.970.70.8